US FDA Commissioner’s Office Plans Involvement In Many Approvals In Potential Major Change

 
• By Sarah Karlin-Smith
  
Stakeholders are concerned the continued involvement of Commissioner Martin Makary's special assistant in other approval procedures could jeopardize the FDA's independent review process. (Screenshot of FDA Video)

More from US FDA

More from Geography